Lichen International (LICN) Common Equity (2021 - 2025)

On a quarterly basis, Common Equity fell 6.64% to $70.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.6 million, a 6.64% decrease, with the full-year FY2025 number at $70.6 million, down 6.64% from a year prior.

Lichen International (LICN) has 5 years of Common Equity data on record, last reported at $70.6 million in Q4 2025.

  • Common Equity reached $70.6 million in Q4 2025 per LICN's latest filing, up from $64.3 million in the prior quarter.
  • Over the last five years, Common Equity for LICN hit a ceiling of $75.6 million in Q4 2024 and a floor of $36.8 million in Q4 2021.
  • A 5-year average of $58.3 million and a median of $62.8 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: skyrocketed 49.41% in 2023, then decreased 6.64% in 2025.
  • Tracing LICN's Common Equity over 5 years: stood at $36.8 million in 2021, then rose by 11.61% to $41.1 million in 2022, then soared by 49.41% to $61.4 million in 2023, then rose by 23.03% to $75.6 million in 2024, then dropped by 6.64% to $70.6 million in 2025.
  • Business Quant data shows Common Equity for LICN at $70.6 million in Q4 2025, $64.3 million in Q2 2025, and $75.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Relx 81.40 Bn 81.16 Bn - 3.15 Bn
2 Rentokil Initial 79.56 Bn 78.10 Bn - 5.49 Bn
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 4.79 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn 9.79 Bn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn 1.32 Bn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn 24.46 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn 5.62 Bn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn 3.28 Bn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn 4.70 Bn
10 Lichen International 4.85 Mn -22.06 Mn - 70.55 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 70.55 Mn
Jun 30, 2025 64.25 Mn
Dec 31, 2024 75.57 Mn
Dec 31, 2023 61.42 Mn
Dec 31, 2022 41.11 Mn
Dec 31, 2021 36.83 Mn